Understanding the Impact and Consequences of Hallucinations and Delusions Associated With Dementia-Related Psychosis

Perspectives From a Neurologist, Geriatric Psychiatrist, and Caregiver

In recognition of World Alzheimer's Month, this broadcast is intended to raise awareness among healthcare professionals and caregivers regarding hallucinations and delusions associated with dementia-related psychosis, including the need for earlier identification and diagnosis.


Meet the Speakers

Alireza Atri, MD, PhD

Alireza Atri, MD, PhD

Director
Banner Sun Health Research Institute
Sun City, AZ

Davangere P. Devanand, MBBS, MD

Davangere P. Devanand, MBBS, MD

Director, Geriatric Psychiatry
Professor of Psychiatry and Neurology
Department of Psychiatry
Columbia University Medical Center
New York, NY

Linda Gregory

Linda Gregory

Caregiver to her mother, who is living with Alzheimer’s disease dementia and experiencing hallucinations and delusions associated with dementia-related psychosis.

Paid consultants of Acadia Pharmaceuticals Inc.


The objectives of the broadcast are to:

Educate

Educate on the patient and caregiver burden of hallucinations and delusions associated with dementia-related psychosis

magnifying glass

Explore the unmet needs in the diagnosis and management of dementia-related hallucinations and delusions

dialogue

Enhance the dialogue between healthcare professionals and caregivers about hallucinations and delusions associated with dementia-related psychosis to help improve earlier identification and diagnosis of these symptoms

This disease-awareness, non-CME program is intended only for healthcare professionals involved in the management of people with dementia-related hallucinations and delusions and is sponsored by Acadia Pharmaceuticals Inc.

©2020 Acadia Pharmaceuticals Inc. Acadia is a registered trademark of Acadia Pharmaceuticals Inc. All rights reserved. DRP-0264 09/20

This website is intended for US healthcare professionals only.

Acadia logo